H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 94 900 VND -0.42%
Market Cap: 7.8T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note

HaTay Pharmaceutical JSC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HaTay Pharmaceutical JSC
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
HaTay Pharmaceutical JSC
VN:DHT
Revenue
â‚«2T
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
9%
I
Imexpharm Corp
VN:IMP
Revenue
â‚«2.2T
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
10%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Revenue
â‚«1.1T
CAGR 3-Years
19%
CAGR 5-Years
7%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Revenue
â‚«1.8T
CAGR 3-Years
7%
CAGR 5-Years
-8%
CAGR 10-Years
2%
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Revenue
â‚«5T
CAGR 3-Years
6%
CAGR 5-Years
-5%
CAGR 10-Years
3%
T
Traphaco JSC
VN:TRA
Revenue
â‚«2.3T
CAGR 3-Years
-16%
CAGR 5-Years
-5%
CAGR 10-Years
4%
No Stocks Found

HaTay Pharmaceutical JSC
Glance View

Market Cap
7.8T VND
Industry
Pharmaceuticals

Ha Tay Pharmaceutical JSC engages in the manufacture, import and export of drugs, medicine, cosmetic and medical equipment. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2008-12-03. The company is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The firm also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The firm announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

DHT Intrinsic Value
18 592.65 VND
Overvaluation 80%
Intrinsic Value
Price
H

See Also

What is HaTay Pharmaceutical JSC's Revenue?
Revenue
2T VND

Based on the financial report for Sep 30, 2024, HaTay Pharmaceutical JSC's Revenue amounts to 2T VND.

What is HaTay Pharmaceutical JSC's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for HaTay Pharmaceutical JSC have been -2% over the past three years , -3% over the past five years , and 9% over the past ten years .

Back to Top